A-A-54564
31 December 1991
COMMERCIAL ITEM DESCRIPTION
SPIRONOLACTOENE AND HYDROCHLOROTHIAZIDE TABLETS
The General Services Administration has authorized the use of this Commercial Item Description as a replacement for Military Specification MIL-S-37490 which is cancelled.
Salient characteristics:
Shall be Spironolactone and Hydrochlorothiazide Tablets.
All ingredients shall be of a pharmaceutical grade.
For Strength 1, shall contain 25 mg of Spironolactone and 25 mg Hydrochlorothiazide per tablet within the applicable assay limits.
For Strength 2, shall contain 50 of Spironolactone and 50 mg of Hydrochlorothiazide per tablet within the applicable assay limits.
Each tablet shall be marked/embossed with a product identification code to identify the active ingredient(s), strength, and manufacturer. The materials used in marking/embossing the dosage forms shall be acceptable to the FDA. The actual code used for the product shall be left to the discretion of the supplier.
Workmanship. The tablets shall be free from defects which detract from their appearance or impair their serviceability.
DISTRIBUTION STATEMENT A. Approved for public release; distribution is unlimited.
For Parts Inquires submit RFQ to Parts Hangar, Inc.
© Copyright 2015 Integrated Publishing, Inc.
A Service Disabled Veteran Owned Small Business